EG

Elvire Gouze

UI Universite Paul Sabatier—Toulouse Iii: 2 patents #1 of 18Top 6%
UD Université Côte D'Azur: 1 patents #1 of 6Top 20%
Pfizer: 1 patents #71 of 301Top 25%
📍 Vallauris, FR: #2 of 23 inventorsTop 9%
Overall (2023): #80,989 of 537,848Top 20%
3
Patents 2023

Issued Patents 2023

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
11814654 Soluble fibroblast growth factor receptor 3 (FGR3) polypeptide for use in the prevention or treatment of skeletal growth retardation disorders 2023-11-14
11702642 Soluble fibroblast growth factor receptor 3 (FGR3) polypeptide for use in the prevention or treatment of skeletal growth retardation disorders 2023-07-18
11697678 Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof Stéphanie Garcia 2023-07-11